![]() |
市場調查報告書
商品編碼
1744427
腦影像設備的全球市場:各產品類型,各種模式,各用途,各終端用戶,各地區,機會,預測,2018年~2032年Brain Imaging Devices Market Assessment, By Product Type, By Modality, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
全球腦部影像設備市場規模預計將從2024年的49.8億美元成長到2032年的89.5億美元,在2025-2032年的預測期內,複合年增長率為7.61%。市場成長歸因於神經系統疾病盛行率的上升、產品創新和研發活動投入的增加,以及支持性監管框架和政策的推出。根據世界衛生組織 (WHO) 的估計,全球超過三分之一的人患有神經系統疾病。神經系統疾病發生率的上升歸因於老年人口的快速增長和生活方式的改變。
腦造影技術的持續創新和快速發展,以及機器學習和人工智慧 (AI) 與腦成像設備的融合,使得疾病的早期發現成為可能。人工智慧工具正被用於自動化影像解讀、檢測人眼不可見的細微變化,並基於海量資料集預測疾病預後。這些技術顯著減輕了醫護人員的工作量,並提高了繁忙臨床環境中的診斷效率。此外,基於雲端的影像解決方案支援遠端檢視、遠端神經科會診和即時協作,這在農村地區尤其實用。穿戴式腦電圖 (EEG) 和便攜式磁振造影 (MRI) 設備的進步提高了設備的易用性和移動性,增強了用戶的便利性,並促進了市場的擴張。
本報告提供全球腦影像設備市場相關調查,提供市場概要,以及各產品類型,各種模式,各用途,各終端用戶,各地區趨勢,及加入此市場的主要企業簡介等資訊。
Global brain imaging devices market is projected to witness a CAGR of 7.61% during the forecast period 2025-2032, growing from USD 4.98 billion in 2024 to USD 8.95 billion in 2032. The market's growth can be attributed to the increasing prevalence of neurological diseases, rising investments in product innovations and research and development activities, and supportive regulatory frameworks and policies. As per the estimates of the World Health Organization (WHO) over 1 in 3 people across the globe are affected by neurological conditions. The increasing incidences of neurological disorders can be attributed to the rapid expansion of the geriatric population and increasing lifestyle changes.
Continuous innovations and rapid advancements in brain imaging technologies along with integration of machine learning and artificial intelligence (AI) with brain imaging devices are allowing early disease detection. AI-powered tools are being used to automate image interpretation, detect subtle changes invisible to the human eye, and predict disease outcomes based on large datasets. These technologies significantly reduce the workload of healthcare professionals and are boosting diagnostic throughput in busy clinical environments. Furthermore, cloud-based imaging solutions allow remote viewing, tele-neurology consultations, and real-time collaboration, which are especially useful in rural regions. Advancements in wearable EEG devices and portable MRI units are ease of use and improving mobility, increasing user convenience and supporting the market's expansion.
Increasing Focus on Research and Development Boosts Market Growth
Research and development activities are fueling innovations and leading to the development of advanced imaging technologies including functional imaging and high-resolution MRIs, among others. Such innovations allow healthcare professionals to monitor the progression of neurological diseases while meeting the rising requirements for non-invasive and precise diagnostic solutions. Additionally, increasing research efforts are also aiding companies in gaining approvals from different regulatory bodies for their products and technologies, further incentivizing them to invest in product innovation. For instance, in May 2025, Hyperfine, Inc. secured clearance from the United States Food and Drug Administration (US FDA) for the latest version of its Swoop system's Optive AI software. The software is able to refine each stage involved in image processing, from postprocessing, noise cancellation, and reconstruction, to image acquisition. Furthermore, the integration of AI-driven enhancements is reducing scan time, streamlining workflow, and supporting rapid clinical decision making. Such advancements are broadening the utility and reach of brain imaging devices, propelling the market's growth.
Rising Prevalence of Neurological Diseases Supports Market Expansion
Due to the expansion of the geriatric population, the incidences of age-related cognitive disorders including Parkinson's disease and Alzheimer's are rapidly increasing. As per the estimates of the Parkinson's Foundation, over 10 million people across the world are living with Parkinson's disease. Brain imaging is essential for diagnosing, monitoring, and managing such conditions as they often require long-term medical oversight, thus bolstering the market's demand. By integrating functional imaging techniques, such as fMRI and PET, it has become possible to observe not just the brain's structure, but also its metabolic and functional activity, enabling physicians to track disease progression in a more precise manner and tailor treatment strategies accordingly. The continued push toward precision medicine and personalized treatments are bolstering the requirement for detailed, patient-specific brain maps, thus augmenting the requirement for advanced brain imaging technologies.
Devices Account for Significant Share of the Market
Devices, in particular MRIs, hold a major share of the brain imaging devices market. This dominance can be attributed to their ability to provide detailed and high-resolution functional and anatomical images of the brain. The superior image quality provided by MRIs allows clinicians to monitor disease progression and detect subtle abnormalities more effectively. Technological advancements, including integration of AI for conducting image analysis are providing improved diagnostic accuracy, expanding the accessibility of MRI technology, and reducing scan times.
In order to further increase physician and patient convenience, the key players of the market are focusing on introducing new products. For instance, in March 2024, FUJIFILM India Private Limited launched the Echelon Synergy MRI Machine at its CT and MRI User Conclave held at Mumbai, India. The system ensures fast exam times, low power consumption, and features sitting flexibility. Such launches are improving patient convenience and positively influencing the market's expansion.
North America Holds Major Market Share
The region's dominance in the market is supported by the high awareness about neurological conditions, easy acceptance of advanced diagnostic technologies, strong presence of leading market players, and high investments in research and development activities. As per the estimates of Alzheimer's Association, over 7 million people in America are living with Alzheimer's. The number is estimated to increase to 13 million by 2050.
Additionally, the increasing popularity and availability of compact and portable brain imaging devices in the region is enhancing patient convenience and accessibility, making it easier for medical professionals to conduct diagnostic procedures in various settings, including remote locations. Such innovations are improving healthcare delivery across North America and supporting the market's expansion. Increasing public fundings and government initiatives towards neuroscience research, including the BRAIN Initiative are also supporting the market's expansion in countries such as the United States.
Impact of the U.S. Tariff on Global Brain Imaging Devices Market
The recently launched tariffs are affecting imports from major manufacturing hubs including, Mexico, China, and the European Union and have imposed significant economic pressure on healthcare providers and medical device manufacturers and strains on supply chains. The escalation in tariffs is forcing various companies to seek alternative suppliers and reassess their sourcing strategies and focus on enhancing their domestic manufacturing capabilities. The increasing financial strains on medical device companies could potentially lead to reduced investments in research and development activities, slowing down innovations in brain imaging technologies.
Key Players Landscape and Outlook
As the burden of neurological conditions is increasing across the globe, the leading market players are focusing on introducing new technologies to ensure their early and accurate detection. For instance, in February 2024, Koninklijke Philips N.V. in collaboration with SyntheticMR AB launched Smart Quant Neuro 3D for diagnosing brain disorders such as dementia, traumatic brain injury, and multiple sclerosis. Smart Quant Neuro 3D combines Synthetic MR's SyMRI NEURO 3D quantitative tissue assessment software and Philips' AI based SmartSpeed image-reconstruction technology. Smart Quant Neuro 3D is effective in measuring myelin, the layer around nerves responsible for ensuring that electrical impulses reach their destination. Such launches allow medical professionals to accurately diagnose brain disorders in a time efficient manner and aid market players in expanding their global presence.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.